1
|
Zeng N, Sun JX, Liu CQ, Xu JZ, An Y, Xu MY, Zhang SH, Zhong XY, Ma SY, He HD, Wang SG, Xia QD. Knowledge mapping of application of image-guided surgery in prostate cancer: a bibliometric analysis (2013-2023). Int J Surg 2024; 110:2992-3007. [PMID: 38445538 DOI: 10.1097/js9.0000000000001232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2023] [Accepted: 02/14/2024] [Indexed: 03/07/2024]
Abstract
BACKGROUND Image-guided surgery (IGS) refers to surgery navigated by medical imaging technology, helping doctors better clarify tumor boundaries, identify metastatic lymph nodes and preserve surrounding healthy tissue function. Recent studies have provided expectable momentum of the application of IGS in prostate cancer (PCa). The authors aim to comprehensively construct a bibliometric analysis of the application of IGS in PCa. METHOD The authors searched publications related to application of IGS in PCa from 2013 to 2023 on the web of science core collection (WoSCC) databases. VOSviewer, CiteSpace, and R package 'bibliometrix' were used for bibliometric analysis. RESULTS Two thousand three eighty-nine articles from 75 countries and 2883 institutions led by the United States were included. The number of publications related to the application of IGS in PCa kept high in the last decade. Johns Hopkins University is the top research institutions. Journal of Nuclear Medicine has the highest popularity as the selection of journal and co-cited journal. Pomper Martin G. had published the most paper. Ali Afshar-Oromieh was co-cited most frequently. The clinical efficacy of PSMA-PET/CT in PCa diagnosis and treatment are main topics in this research field, with emerging focuses on the use of fluorescence imaging guidance technology in PCa. 'PSMA' and 'PET/CT' are the main keywords as long-term research hotspots. CONCLUSION This study is the first bibliometric analysis of researches on application of IGS in PCa with three recognized bibliometric software, providing an objective description and comprehensive guidance for the future relevant investigations.
Collapse
Affiliation(s)
- Na Zeng
- Department and Institute of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, People's Republic of China
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Nandurkar R, van Leeuwen P, Stricker P, Woo H, Kooner R, Yuen C, O'Neill G, Ende D, Cusick T, Ho B, Hickey A, Emmett L. 68Ga-HBEDD PSMA-11 PET/CT staging prior to radical prostatectomy in prostate cancer patients: Diagnostic and predictive value for the biochemical response to surgery. Br J Radiol 2019; 92:20180667. [PMID: 30563350 DOI: 10.1259/bjr.20180667] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
METHODS: We analysed results of 142 males with staging PSMA prior to radical prostatectomy (RP). Data collected included PSMA PET/CT, bone scan (30/142), mpMRI (112/142), and pathological T stage (pT) stage, Gleason score, surgical margins and lymph node status at RP. Prostate-specific antigen (PSA) was documented at staging scan, and following surgery (median 45 days (interquartile range 38-59). A PSA of < 0.03 ng ml-1 was classified as surgical response (SR). Logistic regression was performed for association of pre-operative clinical variables and SR. RESULTS: 97.9% (139/142) of males had positive intraprostatic findings on PSMA. 14.1 % (20/142) of males had further sites of extra prostatic disease identified on PSMA PET. In males with disease confined to the prostate, 82.9 % (92/111) achieved an SR, compared to 28.6 % (4/14) in males with extraprostatic disease identified (lymph node positive and distant metastatic disease) (p < 0.001). On binary logistic regression PSMA had a superior predictive value for SR than Gleason score, PSA (at time of imaging) or pT stage. MRI was less sensitive and more specific for SVI, and less sensitive for nodal involvement. CONCLUSION: Extraprostatic disease identified on staging pre-operative PSMA PET is independently predictive of a poor surgical response to RP, and may indicate a need for a multimodality approach to treatment. ADVANCES IN KNOWLEDGE: This is one of the first studies to correlate the PSMA PET's staging capacity to prostate cancer patient's outcomes to radical prostatectomy and indicates it's potential in predicting which patients will benefit from radical prostatectomy.
Collapse
Affiliation(s)
- Rohan Nandurkar
- 1 Faculty of Medicine, University of New South Wales Sydney , Sydney, NSW , Australia
| | - Pimmeke van Leeuwen
- 2 Clinical Prostate Cancer Research, The Garvan Institute of Medical Research , Sydney, NSW , Australia.,3 Department of Urology, Erasmus Medical Center , Rotterdam , Netherlands
| | - Phillip Stricker
- 2 Clinical Prostate Cancer Research, The Garvan Institute of Medical Research , Sydney, NSW , Australia.,4 Department of Urology, St Vincent's Clinic , Sydney, NSW , Australia
| | - Henry Woo
- 5 Department of Urology, Sydney Adventist Hospital , Sydney, NSW , Australia
| | - Rajdeep Kooner
- 4 Department of Urology, St Vincent's Clinic , Sydney, NSW , Australia
| | - Carlo Yuen
- 4 Department of Urology, St Vincent's Clinic , Sydney, NSW , Australia
| | - Gordon O'Neill
- 4 Department of Urology, St Vincent's Clinic , Sydney, NSW , Australia
| | - David Ende
- 4 Department of Urology, St Vincent's Clinic , Sydney, NSW , Australia
| | - Thomas Cusick
- 2 Clinical Prostate Cancer Research, The Garvan Institute of Medical Research , Sydney, NSW , Australia
| | - Bao Ho
- 6 Department of Nuclear Medicine, St Vincent's Hospital Sydney , Sydney, NSW , Australia
| | - Adam Hickey
- 6 Department of Nuclear Medicine, St Vincent's Hospital Sydney , Sydney, NSW , Australia
| | - Louise Emmett
- 2 Clinical Prostate Cancer Research, The Garvan Institute of Medical Research , Sydney, NSW , Australia.,6 Department of Nuclear Medicine, St Vincent's Hospital Sydney , Sydney, NSW , Australia
| |
Collapse
|